While the anti-tumour mechanisms of CTLA-4 antibodies are not well understood, the generally believed hypothesis is that blocking CTLA-4 causes an increased activation of proliferation of effector T-cells accompanied with a decrease in activated Treg cells (Fife and Bluestone, 2008). Here, CTLA4 is linked to neoplasm.